Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema

European Journal of Ophthalmology

Volumn 21, Issue SUPPL.6, 2011, Pages 56-61

  Habot Wilner, Zohar ^a   Sallam, Ahmed ^a   Pacheco, Patricio A ^a   Do, Helen H ^b   McCluskey, Peter ^b   Lightman, Sue ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cystoid macular edema; Intravitreal triamcinolone acetonide

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; CATARACT; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENDOPHTHALMITIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAOCULAR PRESSURE; LENS DISEASE; LENS INJURY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RELAPSE; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT OUTCOME; UVEITIC MACULAR EDEMA; UVEITIS; VISUAL ACUITY; VITREOUS HEMORRHAGE;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CHEMOTHERAPY, ADJUVANT; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TRIAMCINOLONE ACETONIDE; UVEITIS; VISUAL ACUITY;

EID: 79961001268     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/EJO.2010.6062     Document Type: Review

References (20)

1. Rothova A, Suttorp-van Schulten MS, Treffers WF, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996; 80: 332-6.
2. Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 1996; 80: 844-8.
3. Lardenoye CW, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology 2006; 113: 1446-9.
4. Kiss CG, Barisani-Asenbauer T, Maca S, Richter-Mueksch S, Radner W. Reading performance of patients with uveitisassociated cystoid macular edema. Am J Ophthalmol 2006; 142: 620-4.
5. Kok H, Lau C, Maycock N, McCluskey P, Lightman S. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology 2005; 112: 1916-21.
6. Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Experiment Ophthalmol 2001; 29: 2-6.
7. Antcliff RJ, Spalton DJ, Stanford MR, et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001; 108: 765-72.
8. Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol 2001; 119: 1380-3.
9. Karacorlu M, Mudun B, Ozdemir H, Karacorlu SA, Burumcek E. Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behcet disease. Am J Ophthalmol 2004; 138: 289-91.
10. Angunawela RI, Heatley CJ, Williamson TH, et al. Intravitreal triamcinolone acetonide for refractory uveitic cystoid macular oedema: long-term management and outcome. Acta Ophthalmol Scand 2005; 83: 595-9.
11. Androudi S, Letko E, Meniconi M, Papadaki T, Ahmed M, Foster CS. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema. Ocul Immunol Inflamm 2005; 13: 205-12.
12. Shah A, Branley M. Use of intravitreal triamcinolone in the management of birdshot retinochoroidopathy associated with cystoid macular oedema: a case study over a threeyear period. Clin Experiment Ophthalmol 2005; 33: 442-4.
13. Sivaprasad S, McCluskey P, Lightman S. Intravitreal steroids in the management of macular oedema. Acta Ophthalmol Scand 2006; 84: 722-33.
14. Das-Bhaumik RG, Jones NP. Low-dose intraocular triamcinolone injection for intractable macular oedema and inflammation in patients with uveitis. Eye 2006; 20: 934-7.
15. Morrison VL, Kozak I, LaBree LD, Azen SP, Kayicioglu OO, Freeman WR. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema. Ophthalmology 2007; 114: 334-9.
16. Atmaca LS, Yalçindaǧ FN, Ozdemir O. Intravitreal triamcinolone acetonide in the management of cystoid macular edema in Behçet's disease. Graefes Arch Clin Exp Ophthalmol 2007; 245: 451-6.
17. Choudhry S, Ghosh S. Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema. Clin Experiment Ophthalmol 2007; 35: 713-8.
18. Hogewind BF, Zijlstra C, Klevering BJ, Hoyng CB. Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis. Eur J Ophthalmol 2008; 18: 429-34.
19. Maca SM, Abela-Formanek C, Kiss CG, Sacu SG, Benesch T, Barisani-Asenbauer T. Intravitreal triamcinolone for persistent cystoid macular oedema in eyes with quiescent uveitis. Clin Experiment Ophthalmol 2009; 37: 389-96.
20. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB III, Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003; 110: 681-6.